US Customs Ruling (CROSS)
 HS Code : | | |
|---|
 HTS Code : | | |
|---|
| CAS Number : | |
|---|
Ruling Number :
Issuing Country : UNITED STATES
Date Of Issue : 2017-11-14T00:00:00
Ribociclib (CAS No. 1211441-98-3) in bulk form
The tariff classification of Ribociclib (CAS No. 1211441-98-3) in bulk form, from Taiwan. Ribociclib is a kinase inhibitor that is indicated for the treatment of drug resistant breast cancer. It is specifically used in combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer.
Description : Ribociclib in bulk form
Please importantly note that only the relevant portion of the related US Ruling (Cross) is displayed above. You may refer to the said customs ruling for the entire ruling explanation.
Source : US Customs Ruling (CROSS)
source link :